Zurex Pharma Stock

Zurex Pharma develops a portfolio of antimicrobial products designed to prevent healthcare acquired infections.

Sign up today and learn more about Zurex Pharma Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Zurex Pharma Stock

Zurex Pharmacy is a specialty pharmacy and medical technology company with a novel antimicrobial technology platform. Their company's mission is to develop and commercialize a portfolio of new antimicrobial products designed to prevent healthcare-acquired infections with a focus on surgical site wounds and catheter-related infections. It was founded in 2010 and is headquartered in Middleton, Wisconsin.

Funding History

May 2011$1.0M
May 2012$6.2M
July 2013$846K
July 2014$4.1M
August 2016$6.2M
June 2018$9.0M
June 2020$7.5M


Co-Founder ,President & CEO

Carmine J. Durham

Chief Financial Officer

Alex M. Kasper

Executive Vice President, Regulatory Affairs and Quality Operations

Andrew Morgan

Board of Directors

Gary J. Sherman

Chairman & Board of Directors

Robert B. Truitt

Board of Directors

Michael Liang

Board of Directors

Gary J. Lehman

Board of Directors

Frederick Robertson


EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: